Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 4,626 shares at $70.41 ($332K) on 2022-03-04, disclosed to the SEC on 2022-03-07.
Open-market sale of $332k NVCR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.50 | 803 | $60K | 18.0% |
| 2 | $74.50 | 803 | $60K | 18.0% |
| 3 | $70.41 | 1,510 | $106K | 32.0% |
| 4 | $70.41 | 1,510 | $106K | 32.0% |
| Total | $71.83 avg | 4,626 | $332K | 100% |
| Filing → |
| NVCR | SELL | 2022-05-12 | $531K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |
| NVCR | SELL | 2021-08-03 | $367K | — | Filing → |